SCRI at Mary Crowley

Dallas, Texas 75230

4 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Advanced Lung Cancer, Advanced Solid Tumors, Endometrial Cancer, HER2 Mutation-Related Tumors, HER2-positive Advanced Breast Cancer, HER2-positive Metastatic Breast Cancer, HR-positive, HER2-negative Advanced Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Lung Cancer

Studies at this site

• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors — Recruiting now
• A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. — Recruiting now
• Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer — Starting soon